# Everpure, Inc.: financial statements, quarterly

P · NYSE · CIK 1474432 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/p.md) · [Financials](/companies/p/financials.md) · [Filings](/companies/p/filings.md) · [Insiders](/companies/p/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/p/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-05) | Q4 FY2024 (2024-02-04) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | Q4 FY2025 (2025-02-02) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | Q4 FY2026 (2026-02-01) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [763](/filings/0001628280-24-050852.md) | [790 d](/filings/0001474432-26-000027.md) | [693](/filings/0001628280-25-030567.md) | [764](/filings/0001474432-25-000046.md) | [831](/filings/0001474432-25-000065.md) | [880 d](/filings/0001474432-26-000027.md) | [778](/filings/0001474432-26-000061.md) | [861](/filings/0001474432-26-000088.md) | [964](/filings/0001474432-25-000065.md) | [1,059 d](/filings/0001474432-26-000027.md) | [1,053](/filings/0001474432-26-000061.md) | [1,186](/filings/0001474432-26-000088.md) |
| Cost of revenue | $m | [210](/filings/0001628280-24-050852.md) | [221 d](/filings/0001474432-26-000027.md) | [198](/filings/0001628280-25-030567.md) | [224](/filings/0001474432-25-000046.md) | [248](/filings/0001474432-25-000065.md) | [286 d](/filings/0001474432-26-000027.md) | [242](/filings/0001474432-26-000061.md) | [257](/filings/0001474432-26-000088.md) | [267](/filings/0001474432-25-000065.md) | [319 d](/filings/0001474432-26-000027.md) | [330](/filings/0001474432-26-000061.md) | [375](/filings/0001474432-26-000088.md) |
| Gross profit | $m | [553](/filings/0001628280-24-050852.md) | [569 d](/filings/0001474432-26-000027.md) | [496](/filings/0001628280-25-030567.md) | [540](/filings/0001474432-25-000046.md) | [583](/filings/0001474432-25-000065.md) | [594 d](/filings/0001474432-26-000027.md) | [536](/filings/0001474432-26-000061.md) | [604](/filings/0001474432-26-000088.md) | [697](/filings/0001474432-25-000065.md) | [740 d](/filings/0001474432-26-000027.md) | [723](/filings/0001474432-26-000061.md) | [811](/filings/0001474432-26-000088.md) |
| Research and development | $m | [182](/filings/0001628280-24-050852.md) | [187 d](/filings/0001474432-26-000027.md) | [194](/filings/0001628280-25-030567.md) | [195](/filings/0001474432-25-000046.md) | [200](/filings/0001474432-25-000065.md) | [215 d](/filings/0001474432-26-000027.md) | [222](/filings/0001474432-26-000061.md) | [242](/filings/0001474432-26-000088.md) | [256](/filings/0001474432-25-000065.md) | [243 d](/filings/0001474432-26-000027.md) | [259](/filings/0001474432-26-000061.md) | [294](/filings/0001474432-26-000088.md) |
| Operating income | $m | [74.2](/filings/0001628280-24-050852.md) | [57.4 d](/filings/0001474432-26-000027.md) | [(41.8)](/filings/0001628280-25-030567.md) | [24.9](/filings/0001474432-25-000046.md) | [59.7](/filings/0001474432-25-000065.md) | [42.5 d](/filings/0001474432-26-000027.md) | [(31.2)](/filings/0001474432-26-000061.md) | [4.9](/filings/0001474432-26-000088.md) | [53.9](/filings/0001474432-25-000065.md) | [87.2 d](/filings/0001474432-26-000027.md) | [19.9](/filings/0001474432-26-000061.md) | [63.2](/filings/0001474432-26-000088.md) |
| Interest expense | $m | [2.1](/filings/0001628280-23-041629.md) | [2.0 d](/filings/0001628280-24-013860.md) | [2.0](/filings/0001628280-24-027955.md) | [2.0](/filings/0001474432-25-000046.md) | [1.9](/filings/0001474432-25-000065.md) | [1.8 d](/filings/0001474432-26-000027.md) | [1.8](/filings/0001474432-26-000061.md) | [1.1](/filings/0001474432-26-000088.md) | [0.3](/filings/0001474432-25-000065.md) | [0.3 d](/filings/0001474432-26-000027.md) | [0.2](/filings/0001474432-26-000061.md) | [0.3](/filings/0001474432-26-000088.md) |
| Income tax | $m | [9.0](/filings/0001628280-24-050852.md) | [5.4 d](/filings/0001474432-26-000027.md) | [7.3](/filings/0001628280-25-030567.md) | [8.6](/filings/0001474432-25-000046.md) | [13.2](/filings/0001474432-25-000065.md) | [11.9 d](/filings/0001474432-26-000027.md) | [14.5](/filings/0001474432-26-000061.md) | [3.5](/filings/0001474432-26-000088.md) | [10.9](/filings/0001474432-25-000065.md) | [7.3 d](/filings/0001474432-26-000027.md) | [9.8](/filings/0001474432-26-000061.md) | [(2.0)](/filings/0001474432-26-000088.md) |
| Net income | $m | [70.4](/filings/0001628280-24-050852.md) | [65.4 d](/filings/0001474432-26-000027.md) | [(35.0)](/filings/0001628280-25-030567.md) | [35.7](/filings/0001474432-25-000046.md) | [63.6](/filings/0001474432-25-000065.md) | [42.4 d](/filings/0001474432-26-000027.md) | [(14.0)](/filings/0001474432-26-000061.md) | [47.1](/filings/0001474432-26-000088.md) | [54.8](/filings/0001474432-25-000065.md) | [100 d](/filings/0001474432-26-000027.md) | [24.1](/filings/0001474432-26-000061.md) | [74.1](/filings/0001474432-26-000088.md) |
| Diluted EPS | $ per share | [0.21](/filings/0001628280-24-050852.md) | not reported | [(0.11)](/filings/0001628280-25-030567.md) | [0.10](/filings/0001474432-25-000046.md) | [0.19](/filings/0001474432-25-000065.md) | not reported | [(0.04)](/filings/0001474432-26-000061.md) | [0.14](/filings/0001474432-26-000088.md) | [0.16](/filings/0001474432-25-000065.md) | not reported | [0.07](/filings/0001474432-26-000061.md) | [0.21](/filings/0001474432-26-000088.md) |
| Basic EPS | $ per share | [0.22](/filings/0001628280-24-050852.md) | not reported | [(0.11)](/filings/0001628280-25-030567.md) | [0.11](/filings/0001474432-25-000046.md) | [0.19](/filings/0001474432-25-000065.md) | not reported | [(0.04)](/filings/0001474432-26-000061.md) | [0.14](/filings/0001474432-26-000088.md) | [0.17](/filings/0001474432-25-000065.md) | not reported | [0.07](/filings/0001474432-26-000061.md) | [0.22](/filings/0001474432-26-000088.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-05) | FY2024 (2024-02-04) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | FY2025 (2025-02-02) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | FY2026 (2026-02-01) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [529](/filings/0001628280-24-050852.md) | [703](/filings/0001474432-26-000027.md) | [901](/filings/0001628280-25-030567.md) | [965](/filings/0001474432-25-000046.md) | [895](/filings/0001474432-25-000065.md) | [724](/filings/0001474432-26-000027.md) | [739](/filings/0001474432-26-000061.md) | [888](/filings/0001474432-26-000088.md) | [853](/filings/0001474432-25-000065.md) | [855](/filings/0001474432-26-000088.md) | [838](/filings/0001474432-26-000061.md) | [386](/filings/0001474432-26-000088.md) |
| Current assets | $m | [2,247](/filings/0001628280-23-041629.md) | [2,498](/filings/0001628280-25-015044.md) | [2,448](/filings/0001628280-24-027955.md) | [2,553](/filings/0001628280-24-040066.md) | [2,560](/filings/0001628280-24-050852.md) | [2,567](/filings/0001474432-26-000027.md) | [2,400](/filings/0001628280-25-030567.md) | [2,525](/filings/0001474432-25-000046.md) | [2,652](/filings/0001474432-25-000065.md) | [3,063](/filings/0001474432-26-000088.md) | [3,050](/filings/0001474432-26-000061.md) | [3,318](/filings/0001474432-26-000088.md) |
| Total assets | $m | [3,356](/filings/0001628280-23-041629.md) | [3,656](/filings/0001628280-25-015044.md) | [3,624](/filings/0001628280-24-027955.md) | [3,781](/filings/0001628280-24-040066.md) | [3,854](/filings/0001628280-24-050852.md) | [3,964](/filings/0001474432-26-000027.md) | [3,810](/filings/0001628280-25-030567.md) | [4,027](/filings/0001474432-25-000046.md) | [4,218](/filings/0001474432-25-000065.md) | [4,674](/filings/0001474432-26-000088.md) | [4,750](/filings/0001474432-26-000061.md) | [5,220](/filings/0001474432-26-000088.md) |
| Current liabilities | $m | [1,238](/filings/0001628280-23-041629.md) | [1,366](/filings/0001628280-25-015044.md) | [1,226](/filings/0001628280-24-027955.md) | [1,283](/filings/0001628280-24-040066.md) | [1,445](/filings/0001628280-24-050852.md) | [1,597](/filings/0001474432-26-000027.md) | [1,495](/filings/0001628280-25-030567.md) | [1,534](/filings/0001474432-25-000046.md) | [1,605](/filings/0001474432-25-000065.md) | [1,910](/filings/0001474432-26-000088.md) | [1,886](/filings/0001474432-26-000061.md) | [2,197](/filings/0001474432-26-000088.md) |
| Total liabilities | $m | [2,207](/filings/0001628280-23-041629.md) | [2,386](/filings/0001628280-25-015044.md) | [2,250](/filings/0001628280-24-027955.md) | [2,328](/filings/0001628280-24-040066.md) | [2,444](/filings/0001628280-24-050852.md) | [2,657](/filings/0001474432-26-000027.md) | [2,566](/filings/0001628280-25-030567.md) | [2,708](/filings/0001474432-25-000046.md) | [2,816](/filings/0001474432-25-000065.md) | [3,229](/filings/0001474432-26-000088.md) | [3,308](/filings/0001474432-26-000061.md) | [3,680](/filings/0001474432-26-000088.md) |
| Long-term debt | $m | [100](/filings/0001628280-23-041629.md) | [100](/filings/0001628280-25-015044.md) | [100](/filings/0001628280-24-027955.md) | [100](/filings/0001628280-24-040066.md) | [0.0](/filings/0001628280-24-050852.md) | [0.0](/filings/0001628280-25-015044.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001628280-23-041629.md) | [0.0](/filings/0001628280-25-015044.md) | not reported | not reported | [100](/filings/0001628280-24-050852.md) | [100](/filings/0001474432-26-000027.md) | [100](/filings/0001628280-25-030567.md) | [0.0](/filings/0001474432-25-000046.md) | [0.0](/filings/0001474432-25-000065.md) | [0.0](/filings/0001474432-26-000027.md) | not reported | not reported |
| Shareholders' equity | $m | [1,148](/filings/0001628280-24-050852.md) | [1,270](/filings/0001474432-26-000027.md) | [1,374](/filings/0001474432-25-000046.md) | [1,453](/filings/0001474432-25-000065.md) | [1,411](/filings/0001474432-25-000065.md) | [1,306](/filings/0001474432-26-000088.md) | [1,244](/filings/0001474432-26-000088.md) | [1,319](/filings/0001474432-26-000088.md) | [1,403](/filings/0001474432-25-000065.md) | [1,446](/filings/0001474432-26-000088.md) | [1,442](/filings/0001474432-26-000088.md) | [1,541](/filings/0001474432-26-000088.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-05) | Q4 FY2024 (2024-02-04) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | Q4 FY2025 (2025-02-02) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | Q4 FY2026 (2026-02-01) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [158 d](/filings/0001628280-24-050852.md) | [244 d](/filings/0001474432-26-000027.md) | [222](/filings/0001628280-25-030567.md) | [227 d](/filings/0001474432-25-000046.md) | [97.0 d](/filings/0001474432-25-000065.md) | [209 d](/filings/0001474432-26-000027.md) | [284](/filings/0001474432-26-000061.md) | [212 d](/filings/0001474432-26-000088.md) | [116 d](/filings/0001474432-25-000065.md) | [268 d](/filings/0001474432-26-000027.md) | [180](/filings/0001474432-26-000061.md) | [(136) d](/filings/0001474432-26-000088.md) |
| Capital expenditure | $m | [45.1 d](/filings/0001628280-24-050852.md) | [43.6 d](/filings/0001474432-26-000027.md) | [48.8](/filings/0001628280-25-030567.md) | [60.0 d](/filings/0001474432-25-000046.md) | [61.8 d](/filings/0001474432-25-000065.md) | [56.1 d](/filings/0001474432-26-000027.md) | [72.3](/filings/0001474432-26-000061.md) | [62.0 d](/filings/0001474432-26-000088.md) | [63.4 d](/filings/0001474432-25-000065.md) | [66.6 d](/filings/0001474432-26-000027.md) | [68.4](/filings/0001474432-26-000061.md) | [101 d](/filings/0001474432-26-000088.md) |
| Share repurchases | $m | [22.5 d](/filings/0001628280-24-050852.md) | [21.5 d](/filings/0001474432-26-000027.md) | [0.0](/filings/0001628280-25-030567.md) | [0.0 d](/filings/0001474432-25-000046.md) | [182 d](/filings/0001474432-25-000065.md) | [192 d](/filings/0001474432-26-000027.md) | [120](/filings/0001474432-26-000061.md) | [42.2 d](/filings/0001474432-26-000088.md) | [53.3 d](/filings/0001474432-25-000065.md) | [127 d](/filings/0001474432-26-000027.md) | [84.1](/filings/0001474432-26-000061.md) | [69.0 d](/filings/0001474432-26-000088.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-11-06) | Q1 FY2024 (2023-05-07) | Q2 FY2024 (2023-08-06) | Q3 FY2024 (2023-11-05) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [301](/filings/0001628280-23-041629.md) | [306](/filings/0001628280-24-027955.md) | [310](/filings/0001628280-24-040066.md) | [330](/filings/0001628280-24-050852.md) | [323](/filings/0001628280-25-030567.md) | [343](/filings/0001474432-25-000046.md) | [341](/filings/0001474432-25-000065.md) | [327](/filings/0001474432-26-000061.md) | [338](/filings/0001474432-26-000088.md) | [346](/filings/0001474432-25-000065.md) | [343](/filings/0001474432-26-000061.md) | [346](/filings/0001474432-26-000088.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 333,227,251 at 2026-08-31, from the cover of the [10-Q filed 2026-09-04](/filings/0001474432-26-000088.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.